The wait is over!

We are now accepting samples for sequencing on illumina's NovaSeq X Plus platform.

NovaSeqTM X Plus has just been installed and went live. Novogene is the 1st NGS service provider to publish our validation data on the latest illumina platform. Click here to find out more about how the data compares with sequencing data on NovaSeq 6000.
What do we accept now?
  • Lane sequencing of premade library (375Gb/lane)
  • Human WGS (Minimal 1 NovaSeq X Plus lane)
  • Plant and Animal WGS (Minimal 1 NovaSeq X Plus lane)
Novogene is the first NGS service provider to publish our validation data on the latest Illumina platform!

Check out the validation run with the PhiX library and human whole genome sequencing here. With a maximum data output of 465Gb/lane and an average Q30 >95%, Novogene's NovaSeq X Plus data showcases exceptional performance!


The NovaSeq X Plus platform offers outstanding sequencing power not only for whole genome sequencing but also for whole exome sequencing and transcriptome sequencing. In addition to the previous release of human whole genome sequencing tests on the NovaSeq X Plus, we now have data available for more library types here.
Planning your next sequencing project? Have needs beyond what we can accept? Contact us to have a free non-obligatory project consultation on how you may stretch your budget!
By registering on this page, I consent and agree for Novogene to contact me, assist with my request, and store my information per our privacy policy. You can change your email preferences at any time.

Sequencing read length matters for your genomic research? Do you prefer long-read sequencing for your project?

We are running a registration of interest for PacBio Revio platform. Contact us for more information.

 
About Novogene
Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Our vision is to continue as a global leader in the delivery of genomics services and solutions. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. Novogene is committed to become your trusted genomics partner.
 
About NovogeneAIT Genomics
NovogeneAIT Genomics is a leading multi-omics services and solutions provider headquartered in Singapore. It is formed as a strategic joint venture between Novogene and AITbiotech, a Singapore biotech Company in 2016. With an unwavering commitment to delivering high-quality, swift, and cost-effective omics solutions, NovogeneAIT Genomics has grown to become one of the largest NGS service providers in Southeast Asia. It offers a comprehensive suite of multi-omics services encompasses genomics, transcriptomics, single cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our state-of-the-art sequencing center in Singapore, NovogeneAIT is dedicated to advancing genomic research by offering unmatched data quality that empowers researchers across diverse sectors, including healthcare and agriculture, to realize their research goals.

For more information, visit novogene.com/amea-en/.
 
© 2024 Novogene Co., Ltd. All Rights Reserved
      
 
NovogeneAIT Genomics Pte. Ltd.
(Regional Office for Asia Pacific, Middle-East & Africa)
11 Biopolis Way, #10-11 Helios,
Singapore 138667  
 
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
 
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street, 
Tsim Sha Tsui, Hong Kong